Predicting drug-resistant infections in emergency patients with sepsis
Part of Infections clinical trials.
This study is looking at how well a special model can predict which patients arriving at the emergency room with a severe infection (sepsis) might have a multidrug-resistant (hard-to-treat) infection. By looking at your medical records from your visit, researchers hope to improve treatment decisions and help people like you get the right antibiotics sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were 18 years or older when you came to the emergency room.
- You were seen at the Adult Emergency Department of Hospital Italiano de Buenos Aires during one of these periods: January 1, 2017 – March 20, 2020, or May 1, 2022 – August 10, 2025.
- You had sepsis or septic shock when you first arrived, and you stayed in the hospital for at least 48 hours.
- Bacterial cultures (tests to find the bacteria causing your infection) were done during your first evaluation.
- You started taking antibiotics within the first 48 hours of being in the hospital.
- You were not diagnosed with COVID-19 (SARS-CoV-2 infection) during the first 72 hours of your hospital stay.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is building a tool to predict sepsis, a life-threatening response to infection, in intensive care patients. It may help doctors act faster to prevent complications.
This trial tests a computer tool to help doctors choose the right antibiotic for sepsis early on. It may help improve treatment by providing personalized recommendations based on your condition.
This study aims to find new ways to quickly diagnose sepsis (a severe response to infection) in patients arriving at the emergency room. If successful, these new tests could help doctors start treatment faster.
This trial compares different computer tools that try to predict sepsis—a serious body-wide response to infection—so doctors can spot it earlier. If you’re an adult admitted through the emergency room, your information may be used to test which tool works best.
This trial studies a quick set of tests to figure out whether a person with severe infection (sepsis) will respond to corticosteroids like hydrocortisone. The goal is to guide treatment sooner and avoid ineffective care.
This trial checks whether an electronic “resistance calculator” helps clinicians choose antibiotics for adults hospitalized with suspected sepsis. It compares outcomes when hospitals use the tool versus usual practice to see if antibiotic decisions improve care.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.